Cornerstone Therapeutics Inc (CRTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS
• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

1255 CRESCENT GREEN DRIVE CARY, NC 27518

Focuses on the discovery, development and commercialization of products designed to treat respiratory, inflammatory and critical care diseases through the regulation of the body's inflammatory response.

Are you looking for this stock instead?

View SEC Filings from CRTX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

 
Cornerstone Therapeutics Inc Chart by YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding CRTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CRTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GAFRIC KRISTEN SVP, LEGAL & ADMINISTRATION

  • Officer
 0 2019-08-15 0

LAMOND DAVID

  • Director
 1,925,165 2019-05-13 0

LAMOND PIERRE

LAMOND CHRISTINE

  • 10% Owner
 2,886,530 2019-05-13 0

PFIZER INC

PFIZER VENTURES (US) LLC

PFIZER STRATEGIC INVESTMENT HOLDINGS LLC

  • 10% Owner
 3,249,973 2019-05-13 0

TAKEDA VENTURES, INC.

TAKEDA PHARMACEUTICAL CO LTD

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

TAKEDA PHARMACEUTICALS U.S.A., INC.

  • 10% Owner
 2,679,802 2019-05-13 0

EPIQ CAPITAL GROUP, LLC

BOEDING CHAD

  • IA/MANAGING MEMBER 10% OWNERMANAGING MEMBER OF IA
 5,667,487 2019-05-09 0

LYNCH CASEY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 1,240,580 2019-05-08 0

LOWE CHRISTOPHER P. CHIEF FINANCIAL OFFICER

  • Officer
 0 2019-05-08 0

DOMINY STEPHEN S. CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
 1,436,911 2019-05-08 0

DETKE MICHAEL J. CHIEF MEDICAL OFFICER

  • Officer
 0 2019-05-08 0

HOLSINGER LESLIE EXECUTIVE VICE PRESIDENT

  • Officer
 0 2019-05-08 0

RYAN UNA S

  • Director
 0 2019-05-08 0

MCLOUGHLIN MARGARET

  • Director
 0 2019-05-08 0

YOUNG KEVIN

  • Director
 0 2019-05-08 0

SENNER CHRISTOPHER J.

  • Director
 0 2019-05-08 0

COLLARD CRAIG A CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 No longer subject to file 2014-02-03 0

HEFFERNAN MICHAEL THOMAS

  • Director
 No longer subject to file 2014-02-03 0

MCEWAN ALASTAIR STUART CFO AND TREASURER

  • Officer
 No longer subject to file 2014-02-03 0

ENRIGHT MICHAEL DAVID

  • Director
 No longer subject to file 2014-02-03 0

CODEANNE CHRISTOPHER GEORGE

  • Director
 No longer subject to file 2014-02-03 0

FRANKLIN JOSHUA B VP, STRATEGY & BUS. DEV.

  • Officer
 No longer subject to file 2014-02-03 0

FAILLA ANTON GIORGIO

  • Director
 No longer subject to file 2014-02-03 0

CHIESI FARMACEUTICI SPA

  • 10% Owner
 No longer subject to file 2014-02-03 0

STEPHAN ROBERT

  • Director
 No longer subject to file 2014-02-03 0

ROBERTS ALAN VP, SCIENTIFIC AFFAIRS

  • Officer
 No longer subject to file 2014-02-03 0

DUARTE IRA PRINCIPAL ACCOUNTING OFFICER

  • Officer
 No longer subject to file 2014-02-03 0

VECCHIA MARCO

  • Director
 No longer subject to file 2014-02-03 0

MCBEAN KENNETH PRESIDENT

  • Officer
 No longer subject to file 2014-02-03 0

HARPER JAMES A

  • Director
 No longer subject to file 2014-02-03 0

SHAWVER LAURA

  • Director
 No longer subject to file 2014-02-03 0

MAETZEL ANDREAS VP, CLINICAL AND REGULATORY

  • Officer
 No longer subject to file 2014-02-03 0

POWELL ANDREW KENNETH WILLIAM EVP, GENERAL COUNSEL

  • Officer
 No longer subject to file 2013-08-30 0

CHIESI U.S. CORP

  • 10% Owner
 15,687,538 2013-02-14 0

MORGUS VINCENT T. EVP, FINANCE AND CFO

  • Officer
 49,644 2012-08-22 0

CHIESI ALESSANDRO

  • Director
 0 2012-05-22 0

LUTZ STEVEN MICHAEL EXECUTIVE VICE PRESIDENT

  • Officer
 0 2011-03-02 0

PRICE DAVID CHIEF FINANCIAL OFFICER

  • Officer
 0 2010-03-03 0

DICKSON BRIAN CHIEF MEDICAL OFFICER

  • Officer
 0 2009-09-02 0

CORNERSTONE BIOPHARMA HOLDINGS, LTD.

  • 10% Owner
 No longer subject to file 2009-07-28 0

CHIESI MARIA PAOLA

  • Director
 0 2009-07-28 0

TOWNSEND SCOTT B GENERAL COUNSEL AND EVP LEGAL

  • Officer
 113,043 2009-05-14 0

YOUNG JEFFREY E FORMER VP FINANCE & CAO

  • Officer
 No longer subject to file 2008-11-14 0

PHILLIPS TREVOR FORMER PRESIDENT & CEO

  • Officer
 No longer subject to file 2008-10-31 0

BALDWIN CHENYQUA MICHELE VICE PRESIDENT FINANCE

  • Officer
 0 2008-10-31 0

ESGRO GEORGE ARTHUR VICE PRESIDENT SALES

  • Officer
 0 2008-10-31 0

CAROLINA PHARMACEUTICALS HOLDINGS, LTD.

  • 10% Owner
 1,443,913 2008-10-31 0

CAROLINA PHARMACEUTICALS LTD.

  • 10% Owner
 1,443,913 2008-10-31 0

KELLY THOMAS PATRICK CFO & SVP FINANCE & CORP. DEV,

  • Officer
 90,700 2008-02-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments